Several studies have revealed FOXM1 overexpression is found in different molecular subtypes of BC, including luminal, HER2-responsive and hormone-deprived TNBC participating in initiation, invasion, proliferation, epithelial-mesenchymal transition, metastasis, angiogenesis and therapy resistance in BC patients25,26. This evidence concerns the gene FOXM1 and breast cancer.